BR0011477A - Composição para diminuir a tensão intra-ocular para administração tópica, e, método para diminuir a tensão intra-ocular - Google Patents
Composição para diminuir a tensão intra-ocular para administração tópica, e, método para diminuir a tensão intra-ocularInfo
- Publication number
- BR0011477A BR0011477A BR0011477-4A BR0011477A BR0011477A BR 0011477 A BR0011477 A BR 0011477A BR 0011477 A BR0011477 A BR 0011477A BR 0011477 A BR0011477 A BR 0011477A
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- intraocular tension
- topical administration
- decrease intraocular
- tension
- Prior art date
Links
- 238000011200 topical administration Methods 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 229940123413 Angiotensin II antagonist Drugs 0.000 abstract 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 abstract 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract 1
- 239000004327 boric acid Substances 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
"COMPOSIçãO PARA DIMINUIR A TENSãO INTRA-OCULAR PARA ADMINISTRAçãO TóPICA, E, MéTODO PARA DIMINUIR A TENSãO INTRA-OCULAR". [OBJETIVO] Uma composição para administração tópica tendo excelente atividade na diminuição da tensão intra-ocular é fornecida.[SOLUçãO] Uma composição que diminui a tensão intra-ocular para administração tópica compreende um antagonista da angiotensina II, um ácido bórico e um ácido etilenodiamina tetracético.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16494599 | 1999-06-11 | ||
| PCT/JP2000/003779 WO2000076543A1 (fr) | 1999-06-11 | 2000-06-09 | Composition permettant de reduire la tension oculaire et destinee a l'administration topique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0011477A true BR0011477A (pt) | 2002-03-19 |
Family
ID=15802847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0011477-4A BR0011477A (pt) | 1999-06-11 | 2000-06-09 | Composição para diminuir a tensão intra-ocular para administração tópica, e, método para diminuir a tensão intra-ocular |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6777436B2 (pt) |
| EP (1) | EP1186302B1 (pt) |
| KR (1) | KR100611543B1 (pt) |
| CN (1) | CN1198650C (pt) |
| AT (1) | ATE295721T1 (pt) |
| AU (1) | AU759513B2 (pt) |
| BR (1) | BR0011477A (pt) |
| CA (1) | CA2376780C (pt) |
| CZ (1) | CZ300553B6 (pt) |
| DE (1) | DE60020230T2 (pt) |
| ES (1) | ES2242619T3 (pt) |
| HK (1) | HK1042050A1 (pt) |
| HU (1) | HUP0201466A3 (pt) |
| IL (2) | IL146917A0 (pt) |
| MX (1) | MXPA01012752A (pt) |
| NO (1) | NO328211B1 (pt) |
| NZ (1) | NZ516033A (pt) |
| PL (1) | PL200009B1 (pt) |
| PT (1) | PT1186302E (pt) |
| RU (1) | RU2227740C2 (pt) |
| TR (1) | TR200103603T2 (pt) |
| TW (1) | TWI245639B (pt) |
| WO (1) | WO2000076543A1 (pt) |
| ZA (1) | ZA200109943B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI290470B (en) * | 1999-12-01 | 2007-12-01 | Sankyo Co | The composition for treating glaucoma |
| TW200304812A (en) * | 2002-03-08 | 2003-10-16 | Sankyo Co | An eye drop containing a tetrazole derivative |
| US20050119299A1 (en) * | 2002-03-08 | 2005-06-02 | Sankyo Company, Limited | Ophthalmic solutions containing tetrazole derivatives |
| US20090042962A1 (en) * | 2005-04-21 | 2009-02-12 | Santen Pharmaceutical Co., Ltd. | Therapeutic Agent for Keratoconjunctival Disorder |
| CA2853152C (en) | 2007-11-30 | 2017-04-18 | Toltec Pharmaceuticals, Llc | Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991015206A1 (en) * | 1990-04-05 | 1991-10-17 | E.I. Du Pont De Nemours And Company | Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists |
| CZ154994A3 (en) | 1993-07-02 | 1995-09-13 | Senju Pharma Co | Visual hypotensive agent |
| DE69534339T2 (de) * | 1994-02-08 | 2006-05-24 | Novartis Ag | Behandlung von normaldruckglaukom mit valsartan |
| HUT74734A (en) | 1994-03-16 | 1997-02-28 | Sankyo Co | Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity |
| JPH07324034A (ja) * | 1994-05-30 | 1995-12-12 | Toa Yakuhin Kk | フマル酸ケトチフェン含有の点眼剤 |
-
2000
- 2000-06-09 IL IL14691700A patent/IL146917A0/xx active IP Right Grant
- 2000-06-09 NZ NZ516033A patent/NZ516033A/en not_active IP Right Cessation
- 2000-06-09 RU RU2001133273/15A patent/RU2227740C2/ru not_active IP Right Cessation
- 2000-06-09 WO PCT/JP2000/003779 patent/WO2000076543A1/ja not_active Application Discontinuation
- 2000-06-09 MX MXPA01012752A patent/MXPA01012752A/es active IP Right Grant
- 2000-06-09 DE DE60020230T patent/DE60020230T2/de not_active Expired - Lifetime
- 2000-06-09 HU HU0201466A patent/HUP0201466A3/hu unknown
- 2000-06-09 CA CA002376780A patent/CA2376780C/en not_active Expired - Fee Related
- 2000-06-09 AT AT00935630T patent/ATE295721T1/de not_active IP Right Cessation
- 2000-06-09 PT PT00935630T patent/PT1186302E/pt unknown
- 2000-06-09 TR TR2001/03603T patent/TR200103603T2/xx unknown
- 2000-06-09 PL PL352161A patent/PL200009B1/pl not_active IP Right Cessation
- 2000-06-09 TW TW089111297A patent/TWI245639B/zh not_active IP Right Cessation
- 2000-06-09 ES ES00935630T patent/ES2242619T3/es not_active Expired - Lifetime
- 2000-06-09 CN CNB008113513A patent/CN1198650C/zh not_active Expired - Fee Related
- 2000-06-09 CZ CZ20014415A patent/CZ300553B6/cs not_active IP Right Cessation
- 2000-06-09 EP EP00935630A patent/EP1186302B1/en not_active Expired - Lifetime
- 2000-06-09 AU AU51086/00A patent/AU759513B2/en not_active Ceased
- 2000-06-09 KR KR1020017015901A patent/KR100611543B1/ko not_active IP Right Cessation
- 2000-06-09 BR BR0011477-4A patent/BR0011477A/pt not_active Application Discontinuation
-
2001
- 2001-12-03 ZA ZA200109943A patent/ZA200109943B/en unknown
- 2001-12-04 IL IL146917A patent/IL146917A/en not_active IP Right Cessation
- 2001-12-10 US US10/016,535 patent/US6777436B2/en not_active Expired - Fee Related
- 2001-12-10 NO NO20016023A patent/NO328211B1/no not_active IP Right Cessation
-
2002
- 2002-05-23 HK HK02103878A patent/HK1042050A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9916358A (pt) | Conjunto de composição para uso em cirurgia intra-ocular, e, kit para uso em cirurgia intra-ocular | |
| KR890000098A (ko) | 세포 및 조직 수복제 | |
| NZ324887A (en) | Piperazine and piperidine compounds with analgesic effect | |
| BR0212252A (pt) | Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero | |
| CA2247520A1 (fr) | Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree | |
| GEP20033079B (en) | Pharmaceutical Compositions for Treatment of Diseases Caused by Estrogens Deficiency | |
| ATE221376T1 (de) | Verwendung von nmifa als entzündungshemmer in oberflächlichem saugetier-gewebe | |
| AU2001269688A1 (en) | Combination containing an antifolate and methylmalonic acid lowering agent | |
| UY24308A1 (es) | Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral | |
| GEP20043162B (en) | Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance | |
| SE9403158D0 (sv) | New use of prostaglandins | |
| BR0011477A (pt) | Composição para diminuir a tensão intra-ocular para administração tópica, e, método para diminuir a tensão intra-ocular | |
| DK1187611T3 (da) | Oftalmiske histaminholdige sammensætninger og anvendelse deraf | |
| BR0014461A (pt) | Composto e método para preparar o mesmo | |
| BR9713159A (pt) | Composição substancialmente sólida, composto, composição de sal substancialmente sólida, mistura, e, processo para preparar um composto | |
| AR004691A1 (es) | Nuevos derivados de [3-alcoxi-fenoxi-)-etil]-dialquilamina, una composicion farmaceutica que los comprende, su uso como anestesicos locales y unprocedimiento para su preparacion | |
| BR0107544A (pt) | Composição de promoção de secreção de bile | |
| NZ533483A (en) | Combinations of viscoelastics for use during surgery | |
| EP1353669A4 (en) | METHOD FOR TREATING GLAUCOMA | |
| SE9504662D0 (sv) | New compounds | |
| PT1058544E (pt) | Inibicao da actividade do tnf | |
| TR200102087T2 (tr) | Yeni morfolinbenzamid tuzları | |
| TR200102262T2 (tr) | Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem. | |
| TR200102245T2 (tr) | Koroner müdahale ile ilgili kardiovasküler olayların önlenmesi veya azaltılması için yöntem. | |
| ES2131331T3 (es) | Uso de benzotiofenos para la preparacion de un medicamento para reducir la formacion de cicatrices en la curacion de heridas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |